CNN —
The Biden administration unveiled Tuesday the names of the first 10 drugs subject to price negotiations in Medicare.
They are: Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and Fiasp and certain other insulins made by Novo Nordisk, including NovoLog.
Once set, the negotiated prices take effect in 2026 – though the drug industry has filed multiple lawsuits seeking to derail the effort.
This story is breaking and will be updated.
